Age Ayurveda Nighantu Ayurvedic practitioner? List or verify your practice

Arogyavardhini Vati

Arogyavardhini Vati is a classical Ayurvedic vati, a herbal tablet or pill. Listed in Ayurvedic Formulary of India (AFI) Part I; monographed in Ayurvedic Pharmacopoeia of India (API); recognized by AYUSH Ministry standards. The Ayurvedic Formulary of India (Part I, entry 20:4) lists 13 ingredients, beginning with Rasa (parada)-suddha, Gandhaka-suddha, Lauha-bhasma and Abhra (abhraka)-bhasma.

Key facts
Also known asArogyavardhini Vati, ArogyavardhiniVati
Pharmacopoeia statusListed in Ayurvedic Formulary of India (AFI) Part I; monographed in Ayurvedic Pharmacopoeia of India (API); recognized by AYUSH Ministry standards

Composition

As given in the Ayurvedic Formulary of India, Part I, entry 20:4 (AROGYAVARDHINI GUTIKA), which cites Rasaratnasamuccaya, Visarpadicikitsa; Adhyaya 20; 106-108. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.

#IngredientPartQuantity
1Rasa (parada)-suddha (parada)1 part
2Gandhaka-suddha1 part
3Lauha-bhasma1 part
4Abhra (abhraka)-bhasma (abhraka)1 part
5Sulva (tamra)-bhasma (tamra)1 part
6Haritakipericarp2 parts
7Bibhitaka *pericarp2 parts
8Amalakipericarp2 parts
9Silajatu-suddha *3 parts
10Pura (guggulu)-suddha (guggulu)4 parts
11Citra (eranda) (eranda)root4 parts
12Tikta (katuka) (katuka) *Rt./Rz.22 parts
13Nimba vrksa dalambha (nimba)-svarasa (nimba) *illegible

Cells marked illegible are damaged in the source scan. The ingredient name is shown where it was readable, and nothing is inferred to fill a gap.

* The scanned text was damaged at this row and the name was read from the entry's own Sanskrit verse.

The Formulary gives the dose as 250 to 500 mg, with anupana, the vehicle it is taken with, of ardraka svarasa, honey, nimba svarasa, water. This is what the Formulary records for the classical preparation. It is not a dose for any product, and not advice to take anything.

Source scan of the formulary

The evidence at a glance

4papers on this site for this drug, published 2012 to 2020, every one with a DOI.

  • 4Laboratory and animal studies

A count is not a conclusion and a tier is a study design, not a verdict. Everything listed here is laboratory or animal work, which does not show an effect in people.true See the research index for how papers are tiered.

Names and identification

LanguageName
EnglishArogyavardhini Vati

Where is it described in the classical texts?

Rasa Ratna Samuchchaya (Chapter 20); also described in Rasendra Sara Sangraha and Ayurvedic Formulary of India

How does it work?

  • Hepatoprotective action: Kutki (Picrorhiza kurroa) containing kutkin and picroside protects hepatocytes from oxidative damage and reduces liver enzyme elevation via downregulation of NF-kB pathway
  • Antioxidant defense: Triphala components scavenge free radicals, reduce MDA concentration, and enhance endogenous antioxidant enzymes (glutathione, SOD, catalase)
  • Lipid metabolism regulation: Guggulsterones from Guggulu modulate cholesterol metabolism via farnesoid X receptor (FXR) antagonism and bile acid regulation
  • Anti-inflammatory cascade: Neem (azadirachtin, nimbidin) and Kutki suppress pro-inflammatory cytokines (TNF-alpha, IL-6) and inhibit COX-2 activity
  • Metallic bhasma bioenhancement: Processed iron, copper, and mica calx provide trace mineral supplementation and act as catalysts enhancing bioavailability of herbal constituents

Which traditional uses are supported by research?

These summaries come from the source notes, which do not name the studies behind them.

  • Fatty liver disease (NAFLD/AFLD): clinical and preclinical studies have reported a dose-dependent liver-protective action.
  • Hypolipidemic effects: clinical trials have reported reductions in total cholesterol, LDL and triglycerides.
  • Kushtha (skin disease): traditionally used for skin conditions. Dermatological studies have reported anti-inflammatory and blood-purifying activity.
  • Agni deepana (digestive fire enhancement): traditionally used to kindle digestion. Clinical observations have reported improved appetite and digestive enzyme secretion.

What do recent studies show?

Only studies that could be traced to a published paper are listed here. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.

Recent safety updates

  • Safety evaluation in rats (2012) showed no significant changes in behavioral parameters, liver function, or kidney function tests at doses up to 500 mg/kg with normal cytoarchitecture at all doses; however, long-term use should not exceed 4-6 months without medical supervision due to mercury content
  • Tissue distribution study (2021) confirmed no potential risk of mercury or copper toxicity in patients with liver ailments when prepared by traditional methods at recommended dose and duration
  • Contraindicated in pregnancy and lactation; not recommended for children; patients with renal impairment should avoid use; concurrent use with hepatotoxic drugs requires monitoring

Dosage forms and preparation

Dosage Forms: Vati (tablet/pill), Modern compressed tablet, Capsule (modern)

Standard Dosage: 250 to 500 mg twice or thrice daily, as given in the Ayurvedic Formulary of India, Part I, entry 20:4. The formulary’s anupana: ardraka svarasa, honey, nimba svarasa, water. The formulary attributes this formula to Rasaratnasamuccaya, Visarpadicikitsa; Adhyaya 20; 106-108.

Optimal Timing: Before meals or after meals as directed, typically twice daily

Storage: Store in airtight amber glass containers in a cool, dry place. Protect from moisture. Temperature not exceeding 30°C. Metallic preparations are generally stable.

Marker Compounds: Picroside I, Picroside II (Kutkin), HgS (cinnabar form in Kajjali), Gallic acid (from Triphala), Z-Guggulsterone, E-Guggulsterone

Vehicle (Anupana): Ardraka svarasa, honey, nimba svarasa or water, per the Ayurvedic Formulary of India

Synergistic Combinations

What manufacturers publish about this preparation

Disclosure first. This site is published by Age Ayurveda, which sells Ayurvedic products, though not this preparation. Every cell states what that company's own product page carried when it was read, not our judgement of it. There is no score, no rank and no winner here, and the table is in alphabetical order for that reason.

The formulary entry above fixes the ingredients and the quantity of each. Whether you can check a particular product against it depends on what its manufacturer publishes. Of the 3 companies surveyed that sell a product under this name, this is what their pages carried when they were read on 8 October 2026.

CompanyWhat its product page publishes
BaidyanathNeither an ingredient list nor quantities
Maharishi AyurvedaNeither an ingredient list nor quantities
Patanjali AyurvedAn ingredient list, without quantities

This measures what each company publishes, not the quality of anything it makes. A company that publishes nothing here may make an excellent preparation, and the label in the box is a separate, regulated surface that is not what was read. What disclosure changes is whether a reader, a pharmacist or an answer engine can check a product against the formulary entry it claims.

Method, the full counts across every company surveyed, and what this measurement got wrong the first time: which manufacturers publish what is in the bottle. The URL of every page read is recorded in brand-disclosure.json. If a row here is wrong, including where the correction favours a company other than ours, tell us and we will fix it and say that we did. How the same companies' stated doses compare with the formulary dose, preparation by preparation: Ayurvedic company doses against the Ayurvedic Formulary of India.

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Laboratory and animal studies4

  1. Jamadagni S, Jamadagni P, Angom B and others. 2020. Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl(4) induced chronic hepatotoxicityJournal of Ayurveda and integrative medicine. PMID 32035767 · doi:10.1016/j.jaim.2019.09.005
  2. Kumar G, Srivastava A, Sharma SK and others. 2012. Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical studyAyu. PMID 23559790 · doi:10.4103/0974-8520.105238
  3. Kumar G, Srivastava A, Sharma SK and others. 2012. Safety evaluation of an Ayurvedic medicine, Arogyavardhini vati on brain, liver and kidney in ratsJournal of ethnopharmacology. PMID 22265750 · doi:10.1016/j.jep.2012.01.004
  4. Kumar G, Srivastava A, Sharma SK and others. 2013. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrateJournal of Ayurveda and integrative medicine. PMID 24250146 · doi:10.4103/0975-9476.118707

Reference lists that include it

Gallic acid

Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.